Health Bulletin
Covovax Update
COVOVAX Vaccination at RxDx
From Monday, June 6th, 2022
Age group eligible for this vaccine: 12-17 years
Second Dose: 21 days
Cost: ₹ 386.25
Covovax
It’s the Indian version of Novavax which is already available in the European market.
Covovax is a “SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine” administered intramuscularly, preferably in the deltoid muscle. It is the 2nd one manufactured by Serum Institute of India (SII) besides the Oxford-AstraZeneca vaccine Covishield.
Children aged 12 years and above can receive their Covovax doses at private centres.
Recommended interval between 2 doses (0.5 mL each) are 21 days.
COVID Precaution for all adults!
Attention:
All adults can receive the Precaution dose for COVID Vaccination from 10th April (Sunday), 2022.
This is applicable for private vaccination centres.
Criteria:
a. Age above 18 years
b. Completed 9 months after receiving the 2nd dose of a covid vaccine
Corbevax
COVID Vaccination for 12-13 years and 13-14 years have started from March 16.
Vaccination for this age group is being conducted only in Government CVCs for now. Biological E’s Corbevax has the EUA for vaccination of this age group. The vaccine will be administered in 2 doses (0.5 mL each) at 28 days of Interval.
Market price set at ₹800 + taxes and administration charges (total ₹900).